Navigation Links
US Patent Granted for a New Family of Heat Shock Protein 90 (Hsp90) Inhibitors for the Treatment of Cancer and Neurodegenerative Indications
Date:5/19/2011

occurring pochonin family, Pochonia chlamydospora, and to their syntheses. The invention is further related to use of these compounds as inhibitors of kinases and of the enzyme family known as heat shock protein 90 (Hsp90).

Prior Hsp90 Inhibitors developments: The Hsp90 inhibitors, that have been subject of pre-clinical and clinical studies by a number of pharmaceutical companies over the past decade, have been primarily based on either radicicol, isolated from naturally occurring Diheterospora chlamydosporia, or geldanamycin (which is also a naturally occurring benzoquinone ansamycin antibiotics that can be isolated from Streptomyces hygroscopicus) and its derivative 17 allylamino-17-demethoxygeldanamycin

(17-AAG).

Potential Therapeutic Use of the Company's Hsp90 Inhibitors:  Cancer indications represent the initial target indication for the Company's Hsp90 Inhibitors in the United States. NexGenix has planned a Phase I, Open-Label, multi-center, dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of NexGenix's lead Hsp90 Inhibitor in patients with various solid tumor cancers including enrichment cohorts with recurrent high-grade gliomas and Her2+ breast cancer.  Additional cancer indications are under pre-clinical evaluation as further possibility for clinical trials.

Potential Therapeutic Use in Glioma:  Glioma is the most common primary, malignant brain tumor, with 15,000 new cases presenting each year in the United States alone.  Prognosis is invariably poor, with few treatment options.  Current standard of care includes surgical resection, followed by radiation and/or chemotherapy.  Even with such treatment, median survival for patients with glioma multiforme is 10-15 months, with a one-year survival rate of only 29%, and a five-year survival rate of only 6%.  The very aggressive nature of gliomas is attributed to their highly angiogenic and highly invasive nature. 
'/>"/>

SOURCE NexGenix Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Landmark Patents Issued for ViewRay Technology
2. Breckenridge Pharmaceutical Announces Settlement of Actos® (Pioglitazone Hydrochloride) Patent Litigation
3. GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling
4. Boston Scientific Announces Favorable Jury Verdict Against Cordis Corporation in Stent Patent Litigation
5. Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
6. AcelRx European Patent Covering its NanoTab® Sublingual Delivery Technology for Acute and Breakthrough Pain Pipeline Products Emerges From Opposition Period
7. Rosetta Genomics Announces Issuance of Additional U.S. Patent
8. Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film
9. IRIDEX Granted U.S. Patent for Stepped Angled Laser Handpieces Used in Eye Surgery
10. NeurogesX Receives Notice of Allowance for Patent Covering NGX-1998 Capsaicin Topical Liquid
11. Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014 Ardelyx, Inc. (NASDAQ: ... company focused on cardio-renal, gastrointestinal and metabolic ... 371 patient Phase 2b clinical trial evaluating ... syndrome (IBS-C).  Results from this study demonstrated ... IBS-C symptoms for tenapanor-treated patients compared to ...
(Date:10/1/2014)... , Switzerland , October 1, ... leader in Clinical Genomics and Next Generation Sequencing (NGS) ... allowing clinicians to run full cystic fibrosis analysis in ... the identification and characterisation of all types of variants ... performance. Until now, it has not been ...
(Date:9/30/2014)... 30, 2014  Wrightington, Wigan ... MDRX ) are delighted to announce WWL,s ... new health information system. The system will be implemented ... the way WWL delivers healthcare in the future. ... record of on-time and on-budget system implementations as well ...
Breaking Medicine Technology:Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 2Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 3Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 4
... Calif., Feb. 16, 2012  Questcor Pharmaceuticals, Inc. (NASDAQ: ... of Scott M. Whitcup, M.D., 52, to its ... Vice President, Research & Development and Chief Scientific ... is responsible for leading Allergan,s global research and ...
...   ,The 28th Korea International Medical & Hospital Facility Exhibition(KIMES ... is held at COEX, SEOUL, from Feb.1619. ... national keep-fit, development of medical scholarship and ... Korea E&EX, KMDICA(Korea Medical Devices Industrial Cooperative ...
Cached Medicine Technology:Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors 2Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors 3Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors 4To Take a Glance Cutting Edge Medicine Equipment! 'The 28th International Medical & Hospital Equipment Show' 2To Take a Glance Cutting Edge Medicine Equipment! 'The 28th International Medical & Hospital Equipment Show' 3
(Date:10/1/2014)... Patients with increased inflammation, including those receiving ... risk of depression. For example, a 6-month treatment ... virus infection causes depression in approximately 30% of ... known as fish oil, have a long list ... heart disease and reducing triglyceride levels. These nutritional ...
(Date:10/1/2014)... people to keep their "eyes on the prize" may ... walking, staying focused on a specific target ahead can ... people walk there faster, psychology researchers have found. Their ... around the environment naturally, offers a new strategy to ... interested in exercise if physical activity seems daunting, which ...
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new blog post explaining how ... Senior citizens can purchase a joint life insurance policy ... joint policy is cheaper, but will only pay benefits ... insurance can be used to cover important funeral expenses. ... as the application process is simple and straightforward. ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Bedros Keuilian ... Body Boot Camp fitness boot camps, he’s also considered ... training , with sold out business summits, a line ... marketing consultant to a recent Spike TV reality show ... that now is the time for personal trainers and ...
(Date:10/1/2014)... Reno, Nev. (PRWEB) October 01, 2014 ... through measuring abnormal circadian cellular changes throughout the body, ... Health, Inc. to better address the company’s breadth of ... wearable early breast cancer screening technology. , “Our initial ... breast cancer system which detects abnormal circadian cellular changes ...
Breaking Medicine News(10 mins):Health News:Omega-3 fatty acids may prevent some forms of depression 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 3Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4
... it possible to build supercomputers that can replicate the ... to an implantable chip for interfacing with neurons and ... nanoscience and neuroscience are now advancing each other in ... what this means was the topic of an hour-long ...
... ... ... ... ...
... ... ... ... ...
... the work-weary, the word "vacation" may conjure images of ... But according to published research by a University of ... one of the fastest growing markets in vacation travel ... and into the realm of personal enrichment and fulfillment. ...
... ... February 28th, issued an email entitled "Fear Not!" , ... Pensacola, FL (PRWEB) March 4, 2010 -- ... issued an email entitled "Fear Not!" "We received a message from one of our ...
... , ... ... ... ...
Cached Medicine News:Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 2Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 3Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 4Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 5Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 6Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 7Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 8Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 9Health News:The SCOOTER Store Announces Coast-to-Coast Expansion of Local Stores 2Health News:The SCOOTER Store Announces Coast-to-Coast Expansion of Local Stores 3Health News:The SCOOTER Store Announces Coast-to-Coast Expansion of Local Stores 4Health News:Genealogical tourism redefining leisure travel market, professor says 2Health News:Genealogical tourism redefining leisure travel market, professor says 3Health News:The Power of Prayer Deterred Tsunami's Destruction Ministry Reports 2Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 2Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 3Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 4Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 5
... External Fixator provides a stable ... diameter K wires (0.8 ... hold is utilized to construct ... and positions intervening joints in ...
The Medium External Fixator has a double-rod frame, medium Combination Clamp medium Multi-Pin Clamp, and Carbon Fiber Rods. Rod Attachment for Medium Multi-Pin Clamp allows second rod to be added....
... No need to add individual components for ... of trauma indications. Made of an innovative ... conventional fixators, only much lighter. This means ... and more comfortable for the patient. ,Comes ...
... injectable low osmolar, nonionic, contrast media ... biologically inert when injected intra-arterially. Each ... of ioversol, 3.6 mg of tromethamine ... of edetate calcium disodium as a ...
Medicine Products: